1
40
1
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
URL Address
<a href="http://doi.org/10.1086/653048" target="_blank" rel="noreferrer noopener">http://doi.org/10.1086/653048</a>
Pages
S42–47
Volume
51 Suppl 1
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Recommendations for treatment of hospital-acquired and ventilator-associated pneumonia: review of recent international guidelines.
Publisher
An entity responsible for making the resource available
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Date
A point or period of time associated with an event in the lifecycle of the resource
2010
2010-08
Subject
The topic of the resource
*Practice Guidelines as Topic; Anti-Bacterial Agents/*therapeutic use; Bacteria/drug effects/isolation & purification; Bacterial/diagnosis/*drug therapy; Clinical Trials as Topic; Cross Infection/diagnosis/*drug therapy; Hospitals; Humans; Microbial Sensitivity Tests; Pneumonia; Time Factors; Ventilator-Associated/diagnosis/*drug therapy
Creator
An entity primarily responsible for making the resource
File Thomas M Jr
Description
An account of the resource
Recently published guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia are reviewed for recommendations regarding diagnosis and antimicrobial therapy to assess the implications for development of future clinical trials. Despite some differences (mostly related to likely pathogens), there is a general agreement about the recommended approach to management. All of the reviewed guidelines invariably recommend early, appropriate antimicrobial therapy and avoidance of excessive antimicrobials by deescalation of therapy on the basis of microbiological culture results and the clinical response of the patient. Developers of future clinical trials will need to be mindful of these recommendations to maintain best practice care for each investigator.
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.1086/653048" target="_blank" rel="noreferrer noopener">10.1086/653048</a>
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
*Practice Guidelines as Topic
2010
Anti-Bacterial Agents/*therapeutic use
Bacteria/drug effects/isolation & purification
Bacterial/diagnosis/*drug therapy
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Clinical Trials as Topic
Cross Infection/diagnosis/*drug therapy
Department of Internal Medicine
File Thomas M Jr
Hospitals
Humans
Microbial Sensitivity Tests
NEOMED College of Medicine
Pneumonia
Time Factors
Ventilator-Associated/diagnosis/*drug therapy